Back

Differential associations of cardiorenal-inflammatory markers with incident cardiovascular disease and cancer in the general population

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis as an inflammatory process (2) Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yiqian YANG

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
SMART2 recurrent CVD event risk for stratification of cumulative healthcare costs
Mr J. Ebbers (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Epigenetic vs chronologic age for cardiovascular risk assessment
Doctor R. Ibrahim (Phoenix, US)
Abstract Slides Video
Presentation thumbnail
The additive prognostic value of C-reactive protein for all-cause and cardiovascular mortality across the PREVENT-defined cardiovascular risk continuum: a nationally representative cohort study
Doctor V. Jaiswal (Glenview, US)
Abstract Slides Video
Presentation thumbnail
Long-term cardiovascular risk following COVID-19 hospitalisation in a large US health system: temporal and prediction modelling
Doctor G. Fontana (Thousand Oaks, US)
Abstract Slides Video
Presentation thumbnail
Integrated clinical and polygenic coronary artery disease risk score predicts 10-year progression of coronary artery plaque
Mr B. Weijs (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Atherosclerosis as an inflammatory process (2)

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular and inflammatory biomarkers in cancer patients and their impact on mortality
1 September 2019
thumbnail
Congress Presentation
Predictive value of protein-bound uremic toxins for heart failure events in patients with chronic kidney disease.
21 May 2023
thumbnail
Congress Presentation
Framingham risk score associates with incident cancer and heart failure
21 June 2025
thumbnail
Congress Presentation
High-sensitivity C-Reactive protein predicts post-percutaneous coronary intervention cardiovascular risk with CKD status effect: evidence from a prospective registry study
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources